Quantitative metabolic volumetric product on 18Fluorine-2fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in assessing treatment response to disease-modifying antirheumatic drugs in rheumatoid arthritis: Multiparametric analysis integrating American college of Rheumatology/European League against Rheumatism criteria

Quantitative metabolic volumetric product on 18Fluorine-2fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in assessing treatment response to disease-modifying antirheumatic drugs in rheumatoid arthritis: Multiparametric analysis integrating American college of Rheumatology/European League against Rheumatism criteria

The purpose of this study was to assess the role of fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the evaluation of treatment response evaluation to disease-modifying antirheumatic drug (DMARD) therapy in patients of rheumatoid arthritis (RA). A total of t...

Full description

Bibliographic Details
Main Authors: Nandigam Santosh Kumar, Yogesh Shejul, Ramesh Asopa, Sandip Basu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:World Journal of Nuclear Medicine
Subjects:
18Fluorine-2fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography
2010 American College of Rheumatology/European League Against Rheumatism rheumatoid classification criteria
disease-modifying antirheumatic drugs
metabolic volumetric product
rheumatoid arthritis
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=4;spage=293;epage=302;aulast=Kumar

Internet

http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=4;spage=293;epage=302;aulast=Kumar

Similar Items